UDG Healthcare has reported a rise in revenues and pre-tax profits for the year to the end of September after a year of "substantial progress" for the firm.
Revenues for the year rose by 11% to €2.033 billion while adjusted pre-tax profits increased by 8% to €818m.
The company is proposing a final dividend of 6.95 cent per share. This will give a total dividend for the year of 9.56 cent, up 6% on last year.
In August, the company said that after its move to list solely on the London Stock Exchange it conducted a review to consider if its results should be presented in sterling.
It said that it had decided that based on existing and future geographic profit flows, it will continue to use euro as its reporting currency.
UDG Healthcare said that all five acquisitions completed in 2012 have now been successfully integrated, with the focus now on generating further revenue and cost synergies from these businesses.
The company also said that it has continued with its internationalisation, with the US now contributing 34% of its operating profits, up from 24% in 2012.
"2013 has been a year of substantial progress for the group. Group revenues for the year of €2.03 billion were 11% higher than in 2012. Operating profits have grown by 13%, and earnings per share have increased by 8% on a constant currency basis," commented the company's chief executive Liam FitzGerald.
Mr FitzGerald said that after the integration of the businesses acquired in 2012 and the recent rebranding, UDG Healthcare has further strengthened its position as a leader in the provision of "high quality outsourcing solutions" for healthcare companies across 22 countries.
"The group has considerable long-term financing facilities available and good internally generated cash flow to support our growth objectives. The group holds strong market positions in attractive markets and remains very positive about our future growth prospects," the CEO added.
